Acacia Research (AZG2) AI Stock Analysis

0 Followers

Acacia Research

(Frankfurt:AZG2)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Strong liquidity and conservative capital structureSubstantial liquidity and the absence of parent-company debt provide financial flexibility for acquisitions, organic investment, and business volatility. Non-recourse subsidiary debt further limits direct balance-sheet exposure and supports resilience over the next several quarters.

Negative Factors

Episodic IP revenue limits earnings predictabilityDependence on intermittent licensing outcomes makes consolidated revenue and cash generation difficult to forecast across quarters. Sharing proceeds with inventors, partners and counsel further reduces retained economics, limiting the durability of headline licensing growth.

Acacia Research (AZG2) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 416.70M
Dividend Yield: ―
Average Volume (3M): 200
Price to Earnings (P/E): -16.2
Beta (1Y): 0.41
Revenue Growth: 3.64%
EPS Growth: -182.55%
Country: Germany
Employees: 986
Sector: Industrials
Sector Strength: 63
Industry: Specialty Business Services

Acacia Research Business Overview & Revenue Model

Company Description

Acacia Research Corporation, together with its associated entities, primarily concentrates on acquiring intellectual property and related high-yield assets. A core aspect of its business strategy involves the commercialization and defense of patented...

Acacia Research Earnings Call Summary

Earnings Call Date:Aug 04, 2026(Q2-2026)|% Change Since:-3.05%|Next Earnings Date:May 11, 2022

Earnings Call SentimentPositive

The call communicated strong topline growth and robust operating performance driven largely by a sizable Intellectual Property licensing settlement and solid execution at operating businesses (notably Benchmark). The company also emphasized a healthy balance sheet ($334.6M liquidity) and opportunistic deal pipeline. However, there are notable challenges: a full write‑down of the MalinJ1/Viamet investment, nonrecurring legal expenses in the IP segment, Deflecto's pressured margins during restructuring, and the timing/contingent nature of IP cash flows. On balance, the positive items (material revenue growth, record Benchmark results, liquidity and realized public gains) materially outweigh the lowlights, though investors should be mindful of episodic IP volatility and the recent biotech impairment.

Positive Updates

Sharp Revenue Growth Driven by Licensing

Total company revenue of $114.6M in Q2 2026 versus $51.2M in prior year period — an increase of approximately 124% — driven primarily by strong licensing activity in the Intellectual Property (Wi‑Fi 6) portfolio (license/relation revenue ~$60.6–60.9M).

Negative Updates

Minimal GAAP Net Income

GAAP net income attributable to Acacia was only $47,000 (approximately $0.00 per diluted share) despite strong adjusted results, reflecting significant items and non‑cash impacts.

Company Guidance

Management's forward-looking guidance emphasized maintaining financial flexibility and disciplined, long‑term capital allocation while pursuing selective acquisitions and organic investments (e.g., additional Benchmark wells under type‑curve underwriting), with several concrete metrics cited as context: Q2 total revenue $114.6M (operating segment revenue ex‑IP $53.6M), total company adjusted EBITDA $17.3M (operated segment adjusted EBITDA $22.8M), cash/securities/loans receivable $334.6M and no parent company debt; segment results included Benchmark revenue $20.5M, adj. EBITDA $9.8M and free cash flow $6.5M; Deflecto revenue $27.1M, adj. EBITDA $1.1M; Printronix revenue $6.0M, adj. EBITDA $1.0M and free cash flow $0.9M; Intellectual Property licensing revenue ~$60.6–60.9M with IP adj. EBITDA $10.9M (noting $3.7M of nonrecurring legacy legal expense and that the TP‑Link settlement was booked as AR in Q2 and collected in Q3), consolidated G&A $19.6M, operating income $8.5M, adjusted net income $12.8M ($0.13/sh), GAAP net income $0.05M, book value $557M ($5.71/sh), and total gross indebtedness $90.4M (nonrecourse: Benchmark $59.5M, Deflecto $30.9M); management also said IP amortization has declined vs. 2025 and will remain at a lower run‑rate through next year, Deflecto should see structural operating leverage as demand improves, and AMO Pharma's regulatory feedback increases clarity for AM02 development.

Acacia Research Risk Analysis

Acacia Research disclosed 65 risk factors in its most recent earnings report. Acacia Research reported the most risks in the "Finance & Corporate" category.

Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

0 New Risks

Acacia Research Peers Comparison

Overall Rating

UnderperformOutperform

Sector (63)

Financial Indicators

DE:AZG2 against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
NTIP	54Neutral	$36.35M	-12.51	-7.09%	6.54%	-100.00%	-22.00%

* Industrials Sector Average

Performance Comparison

DE:AZG2 and its peers over the selected period
Show on chart	Ticker	Company Name	Price	Change	% Change
	DE:AZG2	Acacia Research Corp.	3.82	1.04	37.41%
	NTIP	Network-1 Technologies Inc	1.53	0.10	6.99%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Acacia Research AI Stock Analysis